BioSpace News Archive

Aetion® announced new peer-reviewed findings published in Nature Communications.

Xencor, Inc. announced that the first patient has been dosed in XmAb20717-01 (DUET-2)

Vertex Pharmaceuticals Incorporated will report its second quarter 2018 financial results on Wednesday, July 25, 2018 after the financial markets close.

GAVIN Hockey Wealth Specialists is teaming up with CB1 Capital Management, LLC. CB1 invests in the supply chain of cannabinoid-based wellness solutions, products and therapies that address a wide range of unmet medical conditions and use-cases.

Myovant Sciences Ltd. announced the pricing of its underwritten public offering of 3,333,334 of its common shares at a price to the public of $22.50 per share.

ECM Therapeutics, Inc. is a regenerative medicine company that develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM).

Ampio Pharmaceuticals, Inc. announced a basic science manuscript entitled “The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism of Action” authored by Dr. Bar-Or and prominent clinicians has been published online in Biochemistry and Biophysics Reports.

Leaders of Health Education England (HEE), part of the National Health Service (NHS), and St George’s University (SGU) signed a Memorandum of Understanding to enable SGU School of Medicine graduates to undertake postgraduate training in England, with the first intake expected in the autumn of 2018.

Guardant Health announced that it has appointed Leena Das-Young, Pharm.D. to serve as General Manager of its LUNAR program.

Today, breathe with b announced the success of their Indiegogo campaign and the availability of its revolutionary flagship product, b -- a pocket-sized personal trainer for your lungs and mind.